Watson Pays $27M To Exit Drug Inflation MDL

By Sindhu Sundar · December 13, 2011, 10:11 PM EST

Watson Pharmaceuticals Inc. on Tuesday agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login